L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
NeuroPath’s platform captures data and detects events from the daily living activities of patients with neurodegenerative diseases by using state-of-the-art technologies in motion capturing, QoL surveys, wearables and voice detection.
Enghien, Région wallonne, Belgium
Send a message
Brussels / London / Chicago / Mumbai
NeuroPath (www.NeuroPath.life) is a provider of disruptive and innovative solutions to address the needs of Parkinson’s Disease patients, medical practitioners and researchers, worldwide.
Today NeuroPath announces the appointment of Koen Van den Brande to its management team. Van den Brande will be responsible for the solutions roadmap.
Koen Van den Brande is a veteran of the Banking Technology software industry, with over 30 years of experience as a senior executive at worldwide market leaders in productized banking software solutions, such as Misys (now Finastra), Temenos and Polaris, as well as global strategy roles at technology leaders Microsoft and Accenture.
Van den Brande is also a Person with Parkinson’s (PwP) himself, with the condition diagnosed at age 50. He underwent successful brain surgery to introduce deep brains stimulation (DBS) a few years ago.
In 2019, Van den Brande founded KoDe Health together with some friends and presented a well-received proposal at the World Parkinson Congress in Kyoto. The proposal introduced voice-activated monitoring of PwP at home, as a basis for gathering structured and unstructured data. Based on AI analysis of the data, people suffering from the disease and their caregivers would then get feedback on Quality of Life parameters, based on input from medical practitioners, the community and specialized research. NeuroPath’s solutions will now incorporate the know-how developed at KoDe Health.
“I am thrilled to join the NeuroPath team,” said Van den Brande. “It is working on technology which will not only improve the quality of life of patients, but also create a real opportunity to use big data and AI to find a cure.”
Benoit Tas, CEO NeuroPath commented “From the start, NeuroPath has aimed to be truly patient-centric. Strengthening our team with Koen at a pivotal moment in our young company shows that we mean it. He brings his daily life experience coupled with a deep understanding of the technology”
Koen Van den Brande has spent years in India with a base in rural Maharashta, outside Mumbai. This experience has provided him with firsthand knowledge of the challenges faced by vast numbers of PwPs in India.
He can be reached at firstname.lastname@example.org - +32 467 049665
Benoit Tas, CEO NeuroPath can be reached at email@example.com - +32 472 741671
Second place ($35,000): NeuroPath (North America – Midwest)
Based in Belgium, with ties to the Midwest as a MATTER member, NeuroPath’s digital health platform captures data from Parkinson’s patients by using state-of-art technologies to track their physical, mental, and social health.
Benoit Tas, MBA ’95
Mary Beth Arzac, BA ’88, MBA ’97
Koen Van den Brande
Posted by Bill Oliver Wednesday, October 23rd, 2019
For the 11th time in as many years, local economic development officials are hosting a trade mission from Belgium.
The local lead, Brett Cornwell of the Texas A&M system, welcomed more than 60 people representing 30 companies and universities from three Belgian provinces and two other countries.
Wednesday morning’s welcome included a signing ceremony of what was called a collaborative agreement between A&M’s colleges of medicine and veterinary medicine, Belgian research center Multitel, and Belgian based health data platform company NeuroPath.
Please read the full article and listen to the audio tape by following this link:
Start in September 2016 - January 2018
September 2016 - January 2018
Pilot project commitment at 3 hospitals in Belgium Project partners on board
Q1 2018 - Q4 2019
600K equity and 300K grants raised Agreements Texas A&M & Nortwestern Medicine Chicago office
2.2 M subsidies Wallonia 0.4 M subsidies H2020 First product tested , ready Winner 2nd prize Polsky
to be continued ...